Evaluation of quantitative airway-artery dimensions and ratios of normal CT scans: a study from birth to adulthood
07:00Qianting Lv, Rotterdam / NL
2
Small airways disease and emphysema in pre-COPD: a cross-sectional study
07:00Stijn Verleden, Edegem / BE
3
Interstitial lung abnormalities in low-dose CT screening population: risk factors for the development of clinically significant interstitial lung disease
07:00Wonjong Jeong, Seoul / KR
4
General population bronchial parameters: results from the ImaLife study
07:00Ivan Dudurych, Groningen / NL
5
AI-based small pulmonary artery and vein quantification are associated with lung function impairment in Chronic Obstructive Pulmonary Disease
07:00Anastasia K.A.L. Kwee, Utrecht / NL
6
The effect of SilverBeam filter on cyst scores in patients with cystic lung diseases
07:00Chloe Steveson, Adelaide / AU
7
Quantitative computed tomography assessment of interstitial lung disease associated with connective tissue disease
07:00Honghong Guo, Lan Zhou / CN
8
Prognostic implications of clinical imaging and blood biomarkers on progression in fibrotic interstitial lung diseases using quantitative CT analysis
07:00Johannes Wasmayr, Linz / AT
9
Minimal clinically important difference (MCID) for quantitative analysis of progressive pulmonary fibrosis on high-resolution computed tomography (HRCT)
07:00Ludovica Iaccarino, Rome / IT
10
Are pre-existing interstitial lung abnormalities (ILAs) a risk factor for the development of fibrotic changes during follow-up of Covid-19 patients?
07:00Davide Colombi, Piacenza / IT
PEP Subscription Required
This course is only accessible for ESR Premium Education Package subscribers.